Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. (FWB: GBM) is trading at €0.96, about ₹105 at today's EUR/INR rate, as of 30 Sep 2026, 2:00 AM ET, down 4.03% today. Indian residents can buy Inovio Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€0.96
Today's high
€0.96
52 week low
€0.56
52 week high
€2.28
GBM opened at €0.96, closed previously at €1.00, and has traded between €0.56 and €2.28 over the past 52 weeks.
About
Inovio Pharmaceuticals, Inc. is a biotechnology firm focused on researching, developing, and bringing to market DNA-based treatments designed to address and safeguard individuals from conditions linked to human papillomavirus (HPV), various cancers, and infectious diseases. Their innovative DNA medicines platform incorporates precisely engineered SynCon technology, which identifies and refines the genetic blueprint of the intended antigen, along with CELLECTRA smart device technology to facilitate the efficient administration of DNA plasmids. The company's developmental pipeline features several key programs: VGX-3100 for HPV-associated cervical high-grade dysplasia; INO-3107, currently in Phase 1/2 trials for HPV-related recurrent respiratory papillomatosis; INO-3112, a Phase 2 asset for HPV-related Oropharyngeal Squamous Cell Carcinoma; INO-5401, also in Phase 2, targeting glioblastoma multiforme; INO-4201, undergoing Phase 1b investigation for Ebola Virus Disease; INO-4800, which has advanced to Phase 3 for COVID-19; and INO-6160, in Phase 1 for human immunodeficiency virus. Inovio collaborates with an extensive network of partners and allies, including Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. Established in 1983, the company's corporate headquarters are located in Plymouth Meeting, Pennsylvania.
Key statistics
Avg. volume
1.15K
Market cap
€79.27M
P/E Ratio
-1.05
Price-to-sales ratio
0.00
Enterprise value
$42.75M
Free cash flow yield
-114.50%
Debt-to-equity ratio
1.83
Return on equity
-352.53%
ROIC
-259.45%
Beta
1.49
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
$65.34K
Earnings per share
-$1.81
Free cash flow
-$88.92M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$81.96M
Revenue growth
-69.99%
How to buy Inovio Pharmaceuticals from India
Indian residents can buy Inovio Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Inovio Pharmaceuticals and place an order
Find Inovio Pharmaceuticals by name or by its ticker, GBM, and choose an order type. Inovio Pharmaceuticals trades 11:30 am – 11:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Inovio Pharmaceuticals position in EUR and INR. Inovio Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Inovio Pharmaceuticals from India
Trading and taxes when buying Inovio Pharmaceuticals from India
Trading and limits
- Trading hours
- 8:00 am – 8:00 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneInovio Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Inovio Pharmaceuticals stock?
Yes. Inovio Pharmaceuticals (GBM) has been listed on the Frankfurt Stock Exchange since 2005, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Inovio Pharmaceuticals share cost in rupees?
One Inovio Pharmaceuticals share is €0.96 — about ₹105 at an EUR/INR rate of 108.84 on 30 Sep 2026. Both the Inovio Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Inovio Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Inovio Pharmaceuticals shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Inovio Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Inovio Pharmaceuticals pay a dividend?
No. Inovio Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Inovio Pharmaceuticals from India?
The Frankfurt Stock Exchange trades 11:30 am – 11:30 pm IST in Indian time. The window shifts to 12:30 pm – 12:30 am IST when Germany is on standard time. Orders can only execute during that window.
Is Inovio Pharmaceuticals a Germany company, and does that change how it is taxed?
Inovio Pharmaceuticals trades on the Frankfurt Stock Exchange in EUR, but the company is domiciled in United States. Inovio Pharmaceuticals trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Inovio Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Inovio Pharmaceuticals holding, its cost and its closing value.
How do I sell Inovio Pharmaceuticals and bring the money back to India?
You sell during market hours (11:30 am – 11:30 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Inovio Pharmaceuticals?
Yes. Inovio Pharmaceuticals is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.